Skip to main content
Caplight Logo









Unlimited Bio

Unlimited Bio

Private
HondurasHealthcare & Life Scienceshttps://unlimited.bio/

Last Round

Strategic

Oct 22, 2025

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Unlimited Bio is a biotechnology company that develops combinatorial gene therapies and rejuvenation interventions designed to address the systemic processes of aging.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, D2C Brands

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapylongevity treatmentbiohackinganti-agingregulatory arbitragecombinatorial gene therapyplasmid vectorsspecial economic zoneclinical-stage biotechexperimental medicinemedical tourismVEGF gene therapyfollistatin gene therapyhTERT gene therapydirect-to-consumer biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Unlimited Bio Comparables

Compare Unlimited Bio with similar companies based on industry and business-model similarity.

Unlimited Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Minicircle
91%
GARM Clinic
84%
Libella Gene Therapeutics
80%

Unlimited Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicOct 22, 2025
SeedApr 1, 2024

Key People

Founding team and executive leadership

Anna Vakhrusheva

Chief Technology Officer

Executive Team

Unlimited Bio Investors

Notable investors and investment history

Unlimited Bio investors
InvestorRounds
Infinita FundSeed
Immortal DragonsStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 128% MoM, reaching 1.9K.

  • May 17, 2026

    Monthly visitors increased 308% MoM.

Unlimited Bio Filings

Explore SEC and related filing metadata, where available.

Unlimited Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Unlimited Bio's valuation, stock price, and market status.

Is Unlimited Bio a public or private company?

Unlimited Bio is a private company.

What is the current stock price of Unlimited Bio?

Unlimited Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Unlimited Bio worth (valuation)?

Valuation information for Unlimited Bio is not publicly available.

Can I buy Unlimited Bio stock?

Unlimited Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Unlimited Bio's last funding round?

Unlimited Bio's most recent funding round was Strategic on October 22, 2025.

Who are the main investors in Unlimited Bio?

Key investors in Unlimited Bio include Immortal Dragons.

Will Unlimited Bio IPO soon?

No public IPO plans have been announced for Unlimited Bio.

How can I track Unlimited Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Unlimited Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHonduras
Employee Range2
Year Founded2024
Last FundingOct 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?